Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Intestinal epithelial transporters and enzymes involved in water and ion transport constitute a complex physiological system responsible for maintaining fluid and electrolyte balance within the human body. This system includes a variety of membrane-bound proteins such as the Sodium-Hydrogen Exchanger 3 (NHE3), the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR), and the Sodium-Glucose Cotransporter 1 (SGLT1), alongside supporting enzymes like Carbonic Anhydrase (StatPearls, Physiology, Gastrointestinal Water and Electrolytes). These components work coordinately to facilitate the absorption and secretion of ions like Na+, Cl-, and HCO3-, which in turn drives the osmotic movement of water across the intestinal barrier (PubMed, PMC6151335). Dysregulation of these transporters is a primary driver of gastrointestinal disorders, including chronic constipation and various forms of diarrhea (NIH, Gastrointestinal Transport Mechanisms). Therapeutic intervention often targets specific members of this group; for instance, NHE3 inhibitors like Tenapanor reduce sodium absorption to treat constipation, while guanylate cyclase-C agonists like Linaclotide stimulate CFTR-mediated secretion (FDA, Ibsrela Label; Linzess Label). Consequently, this integrated system is a critical focal point for managing both local gastrointestinal symptoms and systemic fluid-related conditions.
Drugs targeting this system work by modulating specific components: guanylate cyclase-C agonists (e.g., linaclotide) increase cGMP to activate CFTR-mediated chloride secretion; NHE3 inhibitors (e.g., tenapanor) block sodium absorption to retain water in the lumen; and chloride channel activators (e.g., lubiprostone) directly increase fluid secretion (FDA, Linzess Label; FDA, Ibsrela Label; FDA, Amitiza Label).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intestinal epithelial transporters and enzymes involved in water and ion transport.